Detalhe da pesquisa
1.
Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
Cell
; 185(3): 493-512.e25, 2022 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35032429
2.
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study.
Infection
; 50(6): 1441-1452, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35420370
3.
Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.
Emerg Infect Dis
; 27(8): 2169-2173, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34102098
4.
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany.
Emerg Infect Dis
; 27(8): 2174-2178, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34102097
5.
Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia.
Haematologica
; 105(5): 1285-1293, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31399521
6.
Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues.
Int J Mol Sci
; 20(16)2019 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31434245
7.
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial.
J Glob Antimicrob Resist
; 32: 44-47, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36572146
8.
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.
JCI Insight
; 8(8)2023 04 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36881474
9.
A proteomic survival predictor for COVID-19 patients in intensive care.
PLOS Digit Health
; 1(1): e0000007, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36812516
10.
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
Clin Microbiol Infect
; 27(10): 1520.e7-1520.e10, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34139335
11.
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
Lancet Respir Med
; 9(11): 1255-1265, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34391547
12.
A time-resolved proteomic and prognostic map of COVID-19.
Cell Syst
; 12(8): 780-794.e7, 2021 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34139154
13.
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.
EClinicalMedicine
; 40: 101099, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34490415